MedTrace Logo

MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

NCT01769560 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 661

Last updated 2015-07-22

No results posted yet for this study

Summary

This study will test whether a tailored, online educational intervention increases HPV vaccine uptake and intent among female college students.

Conditions

  • Human Papillomavirus-Related Carcinoma

Interventions

BEHAVIORAL

MeFirst Tailored Intervention

Participants will be lead through MeFirst, an interactive web-based tool that is tailored to their responses during the survey. This tool provides information regarding HPV Vaccination.

Sponsors & Collaborators

Principal Investigators

  • Vanessa K Dalton, MD, MPH · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01769560 on ClinicalTrials.gov